RPS PharmSci Today

Hosted on Acast. See acast.com/privacy for more information.

Haseeb Ahmad, Managing Director, UK, Ireland & Nordics Novartis Pharmaceuticals and Country President Novartis UK and President of the ABPI is interviewed by Paul Bennett (CEO, RPS), Prof Gino Martini (Chief Scientist, RPS) and Sarah Cahill (Chief Pharmaceutical Officer's Clinical Fellow) about the Novartis response to COVID-19.

Today we cover experimental vaccines and a few existing medicines that are approved for other indications. The RPS, Novartis and the ABPI want to be very clear that they are not endorsing use of these medicines and no treatments have been approved for COVID-19. Their intent is to explain to the society’s listeners the current status of the various clinical studies which are ongoing.

Hosted on Acast. See acast.com/privacy for more information.

In episode 09 of the PharmSci Today podcast, Paul Bennett (CEO, RPS), Prof Gino Martini (RPS Chief Scientist) and Sarah Cahill (Clinical Fellow, RPS) talk to Richard Saynor (CEO, Sandoz).

Richard discusses Sandoz’s response to COVID-19 and how they are maintaining supply chains and supporting clinical trials to combat the coronavirus. Sandoz is one of the largest suppliers of generic medicines in the world and is separate division of Novartis.

Hosted on Acast. See acast.com/privacy for more information.

New developments in pharmaceutical science, with Professor Gino Martini, Chief Scientist at the Royal Pharmaceutical Society.

Gino talks to Dr Hubert Bland from pharmaceutical company Sanofi, discussing the prospects for coronavirus treatments and vaccines.

In this podcast, Sanofi will talk about experimental vaccines and a few existing medicines that are approved for other indications. Sanofi wants to be very clear that use of any of its medicines in covid-19 is off-label, entirely experimental at this stage – therefore unproven. Sanofi wants to caution they are not endorsing use of these medicines. Their intent is to explain to the society’s listeners the current status of these studies.

Hosted on Acast. See acast.com/privacy for more information.

Hosted on Acast. See acast.com/privacy for more information.

New developments in pharmaceutical science, with Professor Gino Martini, Chief Scientist at the Royal Pharmaceutical Society.

This month, Gino talks to Professor David Taylor, Professor Emeritus of Pharmaceutical and Public Health Policy at UCL, about the role of pharmacists in the NHS, the effects of Brexit and investing in the future of healthcare.

Hosted on Acast. See acast.com/privacy for more information.

New developments in pharmaceutical science, with Professor Gino Martini, Chief Scientist at the Royal Pharmaceutical Society.

This month, Helena Rosado of the RPS sits in for Gino and speaks to Dr Janet Halliday about industrial pharmacy, women's health and new drug delivery systems.

Hosted on Acast. See acast.com/privacy for more information.

Gino introduces Dr Amira Guirguis talking about Novel Psychoactive Substances.

This interview was recorded at Swansea as part of the Exploring Global Problems podcast series from Swansea University, where Dr Guirguis is based.

Hosted on Acast. See acast.com/privacy for more information.

Professor Martini talks with Christine Bond, Professor of Primary Care at the University of Aberdeen and also Editor in Chief of the International Journal of Pharmacy Practice.

- How science underpins everything pharmacists do

- The role of the Science Research Board (SRB) in the RPS

Hosted on Acast. See acast.com/privacy for more information.

Hosted on Acast. See acast.com/privacy for more information.